Angiotensin II-induced regulation of the expression and localization of iron metabolism-related genes in the rat kidney

Hypertension Research

Volumn 30, Issue 2, 2007, Pages 195-202

  Ishizaka, Nobukazu ^a   Saito, Kan ^a   Furuta, Kyoko ^a   Matsuzaki, Gen ^a   Koike, Kazuhiko ^a   Noiri, Eisei ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiotensin II; Gene regulation; Hypertension; Iron metabolism

Indexed keywords

ANGIOTENSIN II; FERROPORTIN 1; HEPCIDIN; HYDRALAZINE; IRON; LOSARTAN; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TRANSFERRIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE LOCATION; HOMEOSTASIS; HYPERTENSION; IRON METABOLISM; KIDNEY METABOLISM; KIDNEY TUBULE CELL; MALE; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; IRON; KIDNEY; LIPID METABOLISM; RATS; RATS, INBRED STRAINS; RECEPTORS, TRANSFERRIN; RNA, MESSENGER;

EID: 34047229322     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.30.195     Document Type: Article

References (35)

1. Gunshin H, Mackenzie B, Berger UV, et al: Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-488.
2. Fleming MD, Trenor CC 3rd, Su MA, et al: Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997; 16: 383-386.
3. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC: Nramp2 is mutated in the anemic Bel-grade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci USA 1998; 95: 1148-1153.
4. McKie AT, Marciani P, Rolfs A, et al: A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 2000; 5: 299-309.
5. Donovan A, Brownlie A, Zhou Y, et al: Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 2000; 403: 776-781.
6. Park CH, Valore EV, Waring AJ, Ganz T: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806-7810.
7. Nemeth E, Tuttle MS, Powelson J, et al: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090-2093.
8. Delaby C, Pilard N, Goncalves AS, Beaumont C, Canonne-Hergaux F: Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 2005; 106: 3979-3984.
9. Lu JP, Hayashi K, Awai M: Transferrin receptor expression in normal, iron-deficient and iron-overloaded rats. Acta Pathol Jpn 1989; 39: 759-764.
10. Ward DT, Hamilton K, Burnand R, Smith CP, Tomlinson DR, Riccardi D: Altered expression of iron transport proteins in streptozotocin-induced diabetic rat kidney. Biochim Biophys Acta 2005; 1740: 79-84.
11. Ferguson CJ, Wareing M, Ward DT, Green R, Smith CP, Riccardi D: Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am J Physiol Renal Physiol 2001; 280: F803-F814.
12. Wareing M, Ferguson CJ, Delannoy M, et al: Altered dietary iron intake is a strong modulator of renal DMT1 expression. Am J Physiol Renal Physiol 2003; 285: F1050-F1059.
13. Chung J, Prohaska JR, Wessling-Resnick M: Ferroportin-1 is not upregulated in copper-deficient mice. J Nutr 2004; 134: 517-521.
14. Kulaksiz H, Theilig F, Bachmann S, et al: The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 2005; 184: 361-370.
15. Ishizaka N, Aizawa T, Yamazaki I, et al: Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration. Lab Invest 2002; 82: 87-96.
16. Saito K, Ishizaka N, Aizawa T, et al: Role of aberrant iron homeostasis in the upregulation of transforming growth factor-beta1 in the kidney of angiotensin II-induced hypertensive rats. Hypertens Res 2004; 27: 599-607.
17. Saito K, Ishizaka N, Hara M, et al: Lipid accumulation and transforming growth factor-beta upregulation in the kidneys of rats administered angiotensin II. Hypertension 2005; 46: 1180-1185.
18. Aizawa T, Ishizaka N, Taguchi J, et al: Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 2000; 35: 800-806.
19. Ishizaka N, Saito K, Mori I, Matsuzaki G, Ohno M, Nagai R: Iron chelation suppresses ferritin upregulation and attenuates vascular dysfunction in the aorta of angiotensin II-infused rats. Arterioscler Thromb Vasc Biol 2005; 25: 2282-2288.
20. Andrews NC: Iron homeostasis: insights from genetics and animal models. Nat Rev Genet 2000; 1: 208-217.
21. Moura IC, Centelles MN, Arcos-Fajardo M, et al: Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001; 194: 417-425.
22. Moura IC, Arcos-Fajardo M, Gdoura A, et al: Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 2005; 16: 2667-2676.
23. Canonne-Hergaux F, Gros P: Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice. Kidney Int 2002; 62: 147-156.
24. Hubert N, Hentze MW: Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci U S A 2002; 99: 12345-12350.
25. Nankivell BJ, Tay YC, Boadle RA, Harris DC: Lysosomal iron accumulation in diabetic nephropathy. Ren Fail 1994; 16: 367-381.
26. Njajou OT, Vaessen N, Joosse M, et al: A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 2001; 28: 213-214.
27. Montosi G, Donovan A, Totaro A, et al: Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001; 108: 619-623.
28. Pietrangelo A: The ferroportin disease. Blood Cells Mol Dis 2004; 32: 131-138.
29. Corradini E, Montosi G, Ferrara F, et al: Lack of enterocyte iron accumulation in the ferroportin disease. Blood Cells Mol Dis 2005; 35: 315-318.
30. Ganz T: Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-788.
31. Piperno A, Trombini P, Gelosa M, et al: Increased serum ferritin is common in men with essential hypertension. J Hypertens 2002; 20: 1513-1518.
32. Davis RJ, Corvera S, Czech MP: Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem 1986; 261: 8708-8711.
33. Kanauchi M, Akai Y, Hashimoto T: Transferrinuria in type 2 diabetic patients with early nephropathy and tubulointerstitial injury. Eur J Intern Med 2002; 13: 190-193.
34. Zeller A, Haehner T, Battegay E, Martina B: Diagnostic significance of transferrinuria and albumin-specific dipstick testing in primary care patients with elevated office blood pressure. J Hum Hypertens 2005; 19: 205-209.
35. Murayama S, Hirano T, Sakaue T, Okada K, Ikejiri R, Adachi M: Low-dose candesartan cilexetil prevents early kidney damage in type 2 diabetic patients with mildly elevated blood pressure. Hypertens Res 2003; 26: 453-458.